ES2079327A1 - Formulaciones farmaceuticas de cefaclor. - Google Patents
Formulaciones farmaceuticas de cefaclor.Info
- Publication number
- ES2079327A1 ES2079327A1 ES09402530A ES9402530A ES2079327A1 ES 2079327 A1 ES2079327 A1 ES 2079327A1 ES 09402530 A ES09402530 A ES 09402530A ES 9402530 A ES9402530 A ES 9402530A ES 2079327 A1 ES2079327 A1 ES 2079327A1
- Authority
- ES
- Spain
- Prior art keywords
- cefaclor
- pharmaceutical formulations
- manufacture
- dispersible tablets
- formulations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nutrition Science (AREA)
- Communicable Diseases (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Oncology (AREA)
- Physiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
Abstract
FORMULACIONES FARMACEUTICAS DE CEFACLOR. LAS FORMULACIONES FARMACEUTICAS DE CEFACLOR, ADECUADAS PARA ELABORAR COMPRIMIDOS DISPERSABLES POR COMPRESION DIRECTA, COMPRENDEN EL ANTIBIOTICO CEFACLOR EN UNA CANTIDAD COMPRENDIDA ENTRE EL 35 POR CIENTO Y EL 50 POR CIENTO EN PESO RESPECTO AL TOTAL DE LA FORMULACION JUNTO CON EXCIPIENTES Y COADYUVANTES APROPIADOS, SELECCIONADOS ENTRE DISGREGANTES, DILUYENTES, LUBRIFICANTES, ANTIADHERENTES, EDULCORANTES, AROMATIZANTES Y, OPCIONALMENTE, SABORIZANTES, OPACIFICANTES Y COLORANTES. ESTAS FORMULACIONES SON ADECUADAS PARA ELABORAR COMPRIMIDOS DISPERSABLES QUE SE DISGREGAN ANTES DE TRES MINUTOS EN AGUA A 19 -21 C Y SON ADECUADOS PARA EL TRATAMIENTO DE LAS INFECCIONES CAUSADAS POR CEPAS DE BACTERIAS SENSIBLES A CEFACLOR.
Priority Applications (37)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES09402530A ES2079327B1 (es) | 1994-12-13 | 1994-12-13 | Formulaciones farmaceuticas de cefaclor. |
AT95304976T ATE201984T1 (de) | 1994-12-13 | 1995-07-17 | Pharmazeutische zubereitungen enthaltend cefaclor |
DK95304976T DK0716852T3 (da) | 1994-12-13 | 1995-07-17 | Farmaceutiske cefaclorformuleringer |
EP95304976A EP0716852B1 (en) | 1994-12-13 | 1995-07-17 | Pharmaceutical formulations of cefaclor |
DE0716852T DE716852T1 (de) | 1994-12-13 | 1995-07-17 | Pharmazeutische Zubereitungen enthaltend Cefaclor |
EP00126491A EP1086690A3 (en) | 1994-12-13 | 1995-07-17 | Pharmaceutical formulations of cefaclor |
DE69521275T DE69521275T2 (de) | 1994-12-13 | 1995-07-17 | Pharmazeutische Zubereitungen enthaltend Cefaclor |
EP00126490A EP1086689A3 (en) | 1994-12-13 | 1995-07-17 | Pharmaceutical formulations of cefaclor |
ES95304976T ES2091738T3 (es) | 1994-12-13 | 1995-07-17 | Formulados farmaceuticos que contienen cefaclor. |
SI9530516T SI0716852T1 (en) | 1994-12-13 | 1995-07-17 | Pharmaceutical formulations of cefaclor |
PT95304976T PT716852E (pt) | 1994-12-13 | 1995-07-17 | Formulacoes farmaceuticas a base de cefaclor |
IL11464295A IL114642A (en) | 1994-12-13 | 1995-07-18 | Pharmaceutical compositions containing cefaclor |
PE1995274137A PE5196A1 (es) | 1994-12-13 | 1995-07-18 | Formulaciones farmaceuticas de cefaclor |
HU9502160A HUT73792A (en) | 1994-12-13 | 1995-07-18 | Pharmaceutical formulation of cefaclor, dispersible tablets from them and process for producing these tablets |
CO95032103A CO4410176A1 (es) | 1994-12-13 | 1995-07-19 | Formulaciones farmaceuticas de cefaclor |
NZ272611A NZ272611A (en) | 1994-12-13 | 1995-07-19 | The manufacturing dispersible tablets of cefaclor by direct compression |
AU25094/95A AU702585B2 (en) | 1994-12-13 | 1995-07-20 | Pharmaceutical formulations of cefaclor |
ZA956411A ZA956411B (en) | 1994-12-13 | 1995-08-01 | Pharmaceutical formulations of cefaclor |
PL95309863A PL181437B1 (pl) | 1994-12-13 | 1995-08-02 | Kompozycja farmaceutyczna zawierajaca cefaklor, tabletka dyspergowalna zawierajaca cefaklor oraz sposób wytwarzania tabletki dyspergowalnejzawierajacej cefaklor PL PL PL PL PL PL PL PL PL PL |
CZ19951998A CZ287248B6 (en) | 1994-12-13 | 1995-08-03 | Pharmaceutical preparation for preparing dispersible tablets by direct compression and containing as active substance cefaclor |
KR1019950024359A KR100350565B1 (ko) | 1994-12-13 | 1995-08-08 | 세파클로르의약제학적제제 |
NO953192A NO309925B1 (no) | 1994-12-13 | 1995-08-14 | FremgangsmÕte for fremstilling av en dispergerbar tablett omfattende cefaclor |
FI953887A FI953887A (fi) | 1994-12-13 | 1995-08-17 | Kefaklorin farmaseuttisia formulaatioita |
RU95113968/14A RU2150276C1 (ru) | 1994-12-13 | 1995-08-18 | Фармацевтическая препаративная форма цефаклора и способ ее получения |
TW084109243A TW492875B (en) | 1994-12-13 | 1995-09-02 | Pharmaceutical formulations of cefaclor |
CA002158511A CA2158511A1 (en) | 1994-12-13 | 1995-09-18 | Pharmaceutical formulations of cefaclor |
YU60795A YU60795A (sh) | 1994-12-13 | 1995-09-18 | Farmaceutske formulacije cefaklora |
TR95/01165A TR199501165A1 (tr) | 1994-12-13 | 1995-09-25 | Sefaklorun farmasötik formülasyonlari. |
US08/542,853 US5861141A (en) | 1994-12-13 | 1995-10-13 | Pharmaceutical formulations of cefaclor |
BR9504573A BR9504573A (pt) | 1994-12-13 | 1995-10-26 | Formulaçao farmaceutica adequada para fabricaçao de tabletes dispersiveis por compressao direta tablete de cefaclor dispersivel e processo para fabricaçao de um tablete dispersivel contendo cefaclor |
MYPI95003503A MY114687A (en) | 1994-12-13 | 1995-11-17 | Pharmaceutical formulations of cefaclor |
JP7322647A JPH08208484A (ja) | 1994-12-13 | 1995-12-12 | セファクロル含有医薬配合物 |
UA95125252A UA34479C2 (uk) | 1994-12-13 | 1995-12-12 | Фармацевтична препаративна форма цефаклору та спосіб її одержання |
CNB951213199A CN1136852C (zh) | 1994-12-13 | 1995-12-13 | 头孢克罗的制药用配方 |
GR960300062T GR960300062T1 (en) | 1994-12-13 | 1996-11-30 | Pharmaceutical formulations of cefaclor |
HK98113978A HK1012574A1 (en) | 1994-12-13 | 1998-12-17 | Pharmaceutical formulations of cefaclor |
GR20010401363T GR3036503T3 (en) | 1994-12-13 | 2001-08-31 | Pharmaceutical formulations of cefaclor |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ES09402530A ES2079327B1 (es) | 1994-12-13 | 1994-12-13 | Formulaciones farmaceuticas de cefaclor. |
Publications (2)
Publication Number | Publication Date |
---|---|
ES2079327A1 true ES2079327A1 (es) | 1996-01-01 |
ES2079327B1 ES2079327B1 (es) | 1996-08-01 |
Family
ID=8288235
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES09402530A Expired - Lifetime ES2079327B1 (es) | 1994-12-13 | 1994-12-13 | Formulaciones farmaceuticas de cefaclor. |
ES95304976T Expired - Lifetime ES2091738T3 (es) | 1994-12-13 | 1995-07-17 | Formulados farmaceuticos que contienen cefaclor. |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES95304976T Expired - Lifetime ES2091738T3 (es) | 1994-12-13 | 1995-07-17 | Formulados farmaceuticos que contienen cefaclor. |
Country Status (32)
Country | Link |
---|---|
US (1) | US5861141A (es) |
EP (3) | EP0716852B1 (es) |
JP (1) | JPH08208484A (es) |
KR (1) | KR100350565B1 (es) |
CN (1) | CN1136852C (es) |
AT (1) | ATE201984T1 (es) |
AU (1) | AU702585B2 (es) |
BR (1) | BR9504573A (es) |
CA (1) | CA2158511A1 (es) |
CO (1) | CO4410176A1 (es) |
CZ (1) | CZ287248B6 (es) |
DE (2) | DE69521275T2 (es) |
DK (1) | DK0716852T3 (es) |
ES (2) | ES2079327B1 (es) |
FI (1) | FI953887A (es) |
GR (2) | GR960300062T1 (es) |
HK (1) | HK1012574A1 (es) |
HU (1) | HUT73792A (es) |
IL (1) | IL114642A (es) |
MY (1) | MY114687A (es) |
NO (1) | NO309925B1 (es) |
NZ (1) | NZ272611A (es) |
PE (1) | PE5196A1 (es) |
PL (1) | PL181437B1 (es) |
PT (1) | PT716852E (es) |
RU (1) | RU2150276C1 (es) |
SI (1) | SI0716852T1 (es) |
TR (1) | TR199501165A1 (es) |
TW (1) | TW492875B (es) |
UA (1) | UA34479C2 (es) |
YU (1) | YU60795A (es) |
ZA (1) | ZA956411B (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2231369T3 (es) * | 1996-02-29 | 2005-05-16 | Fujisawa Pharmaceutical Co., Ltd. | Granulo de disgregacion rapida de un edulcorante sintetico que contiene acido silicico y/o dioxido de silicio. |
AU1150799A (en) * | 1997-10-10 | 1999-05-03 | Yamanouchi Europe B.V. | Oral compositions containing a cephalosporin antibiotic |
PL197077B1 (pl) * | 1998-12-01 | 2008-02-29 | Reddys Lab Inc Dr | Kompozycja farmaceutyczna zawierająca 5-[[4-[3-metylo-4-okso-3,4-dihydro-2-chinazolinylo]metoksy]fenylometylo]-tiazolidyno-2,4-dion lub jego sól dopuszczalną do stosowania w farmacji i sposób jej wytwarzania |
DE10005017A1 (de) * | 2000-02-04 | 2001-08-09 | Cognis Deutschland Gmbh | Duftstofftabletten |
JP2004531537A (ja) * | 2001-05-01 | 2004-10-14 | ファイザー・プロダクツ・インク | 一様な薬剤分布と効力を有する低用量製薬組成物の製造方法 |
US7151432B2 (en) | 2001-09-19 | 2006-12-19 | Immersion Corporation | Circuit and method for a switch matrix and switch sensing |
GB0209265D0 (en) | 2002-04-23 | 2002-06-05 | Novartis Ag | Organic compounds |
TW200404550A (en) * | 2002-07-08 | 2004-04-01 | Sankyo Co | Cepharospolin formulation for oral use |
JP4526247B2 (ja) * | 2002-07-08 | 2010-08-18 | 第一三共株式会社 | 経口用セファロスポリン製剤 |
US8968768B2 (en) * | 2004-03-29 | 2015-03-03 | Wyeth Llc | Phytosterol nutritional supplements |
CA2560595C (en) | 2004-03-29 | 2013-01-22 | Wyeth | Multi-vitamin and mineral nutritional supplements |
US9198862B2 (en) | 2005-07-22 | 2015-12-01 | Rubicon Research Private Limited | Dispersible tablet composition |
CA2618977C (en) | 2005-08-10 | 2014-10-21 | Shionogi & Co., Ltd. | Orally disintegratable tablet |
CN102579455B (zh) * | 2012-03-19 | 2014-02-19 | 迪沙药业集团有限公司 | 一种稳定的头孢克洛咀嚼组合物 |
WO2017045742A1 (de) * | 2015-09-14 | 2017-03-23 | Merck Patent Gmbh | Formulierung mit kontrollierter, verzögerter wirkstoffreisetzung |
CN113750066B (zh) * | 2021-10-12 | 2022-12-02 | 上海金城素智药业有限公司 | 一种具有临床优势的头孢克洛制剂及其制备方法和应用 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0129382A2 (en) * | 1983-06-15 | 1984-12-27 | Shionogi & Co., Ltd. | Long-acting formulation of cefaclor and its preparation |
EP0319074A1 (en) * | 1987-11-30 | 1989-06-07 | Brocades Pharma B.V. | Pharmaceutical composition and process for its preparation |
FR2669221A1 (fr) * | 1990-11-15 | 1992-05-22 | Rhone Poulenc Sante | Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique. |
Family Cites Families (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2259646C2 (de) * | 1972-12-06 | 1984-11-22 | Hoechst Ag, 6230 Frankfurt | Hochdosierte Tabletten von Cephalosporin-Derivaten sowie Verfahren zu ihrer Herstellung |
YU36970B (en) | 1973-02-23 | 1984-08-31 | Lilly Co Eli | Process for obtaining 7-(amino)-acylamido-3-halocephalosporins |
US3925372A (en) | 1973-02-23 | 1975-12-09 | Lilly Co Eli | Alpha-aminoacyl-3-halo cephalosporins |
US4143129A (en) * | 1975-10-11 | 1979-03-06 | Lilly Industries Limited | Cephalexin tablets |
GB2066662B (en) * | 1979-12-21 | 1984-02-15 | Glaxo Group Ltd | Cephalexin powder compositions containing silicon dioxide |
NZ198241A (en) * | 1980-09-27 | 1983-12-16 | Beecham Group Ltd | Tablet containing amoxycillin and potassium clavulanate |
EP0181966A1 (en) * | 1984-11-13 | 1986-05-28 | Gist-Brocades N.V. | Compression-coated dispersible tablets |
DE3887179T2 (de) * | 1987-03-02 | 1994-06-16 | Brocades Pharma Bv | Pharmazeutische Zusammensetzung, pharmazeutisches Granulat und Verfahren zu ihrer Herstellung. |
DE3838431A1 (de) * | 1988-11-12 | 1990-05-17 | Bayer Ag | Ibuprofen-brausezubereitungen |
GB9009473D0 (en) * | 1990-04-27 | 1990-06-20 | Beecham Group Plc | Pharmaceutical formulation |
EP0487774B1 (en) * | 1990-11-29 | 1994-10-26 | Wei Ming Pharmaceutical Mfg. Co. Ltd. | A direct tabletting auxiliary |
EP0522128B1 (en) * | 1991-01-30 | 1996-01-17 | The Wellcome Foundation Limited | Water-dispersible tablets |
GB9109862D0 (en) * | 1991-05-08 | 1991-07-03 | Beecham Lab Sa | Pharmaceutical formulations |
IT1251999B (it) * | 1991-11-11 | 1995-05-27 | Opos Biochimica Srl | Forma cristallina di un antibiotico cefalosporinico |
PL171630B1 (pl) * | 1992-04-30 | 1997-05-30 | Schering Corp | Preparat hydratowanego ceftibutenu i sposób wytwarzania preparatu hydratowanego ceftibutenu PL PL PL PL PL PL PL PL PL |
US5503846A (en) * | 1993-03-17 | 1996-04-02 | Cima Labs, Inc. | Base coated acid particles and effervescent formulation incorporating same |
US5506248A (en) * | 1993-08-02 | 1996-04-09 | Bristol-Myers Squibb Company | Pharmaceutical compositions having good dissolution properties |
US5616344A (en) * | 1994-06-14 | 1997-04-01 | Fuisz Technologies Ltd. | Apparatus and process for strengthening low density compression dosage units and product therefrom |
US5895664A (en) * | 1993-09-10 | 1999-04-20 | Fuisz Technologies Ltd. | Process for forming quickly dispersing comestible unit and product therefrom |
US5622719A (en) * | 1993-09-10 | 1997-04-22 | Fuisz Technologies Ltd. | Process and apparatus for making rapidly dissolving dosage units and product therefrom |
US5595761A (en) * | 1994-01-27 | 1997-01-21 | The Board Of Regents Of The University Of Oklahoma | Particulate support matrix for making a rapidly dissolving tablet |
US5605889A (en) * | 1994-04-29 | 1997-02-25 | Pfizer Inc. | Method of administering azithromycin |
-
1994
- 1994-12-13 ES ES09402530A patent/ES2079327B1/es not_active Expired - Lifetime
-
1995
- 1995-07-17 DK DK95304976T patent/DK0716852T3/da active
- 1995-07-17 DE DE69521275T patent/DE69521275T2/de not_active Expired - Fee Related
- 1995-07-17 ES ES95304976T patent/ES2091738T3/es not_active Expired - Lifetime
- 1995-07-17 DE DE0716852T patent/DE716852T1/de active Pending
- 1995-07-17 SI SI9530516T patent/SI0716852T1/xx unknown
- 1995-07-17 EP EP95304976A patent/EP0716852B1/en not_active Expired - Lifetime
- 1995-07-17 PT PT95304976T patent/PT716852E/pt unknown
- 1995-07-17 EP EP00126490A patent/EP1086689A3/en not_active Withdrawn
- 1995-07-17 AT AT95304976T patent/ATE201984T1/de not_active IP Right Cessation
- 1995-07-17 EP EP00126491A patent/EP1086690A3/en not_active Withdrawn
- 1995-07-18 HU HU9502160A patent/HUT73792A/hu unknown
- 1995-07-18 PE PE1995274137A patent/PE5196A1/es not_active Application Discontinuation
- 1995-07-18 IL IL11464295A patent/IL114642A/xx not_active IP Right Cessation
- 1995-07-19 NZ NZ272611A patent/NZ272611A/xx unknown
- 1995-07-19 CO CO95032103A patent/CO4410176A1/es unknown
- 1995-07-20 AU AU25094/95A patent/AU702585B2/en not_active Ceased
- 1995-08-01 ZA ZA956411A patent/ZA956411B/xx unknown
- 1995-08-02 PL PL95309863A patent/PL181437B1/pl not_active IP Right Cessation
- 1995-08-03 CZ CZ19951998A patent/CZ287248B6/cs not_active IP Right Cessation
- 1995-08-08 KR KR1019950024359A patent/KR100350565B1/ko not_active IP Right Cessation
- 1995-08-14 NO NO953192A patent/NO309925B1/no unknown
- 1995-08-17 FI FI953887A patent/FI953887A/fi not_active IP Right Cessation
- 1995-08-18 RU RU95113968/14A patent/RU2150276C1/ru not_active IP Right Cessation
- 1995-09-02 TW TW084109243A patent/TW492875B/zh not_active IP Right Cessation
- 1995-09-18 YU YU60795A patent/YU60795A/sh unknown
- 1995-09-18 CA CA002158511A patent/CA2158511A1/en not_active Abandoned
- 1995-09-25 TR TR95/01165A patent/TR199501165A1/xx unknown
- 1995-10-13 US US08/542,853 patent/US5861141A/en not_active Expired - Fee Related
- 1995-10-26 BR BR9504573A patent/BR9504573A/pt not_active IP Right Cessation
- 1995-11-17 MY MYPI95003503A patent/MY114687A/en unknown
- 1995-12-12 JP JP7322647A patent/JPH08208484A/ja active Pending
- 1995-12-12 UA UA95125252A patent/UA34479C2/uk unknown
- 1995-12-13 CN CNB951213199A patent/CN1136852C/zh not_active Expired - Fee Related
-
1996
- 1996-11-30 GR GR960300062T patent/GR960300062T1/el unknown
-
1998
- 1998-12-17 HK HK98113978A patent/HK1012574A1/xx not_active IP Right Cessation
-
2001
- 2001-08-31 GR GR20010401363T patent/GR3036503T3/el not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0129382A2 (en) * | 1983-06-15 | 1984-12-27 | Shionogi & Co., Ltd. | Long-acting formulation of cefaclor and its preparation |
EP0319074A1 (en) * | 1987-11-30 | 1989-06-07 | Brocades Pharma B.V. | Pharmaceutical composition and process for its preparation |
FR2669221A1 (fr) * | 1990-11-15 | 1992-05-22 | Rhone Poulenc Sante | Procede de preparation par compression directe de comprimes de derives de l'acide cephalosporanique. |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2079327A1 (es) | Formulaciones farmaceuticas de cefaclor. | |
IL114641A (en) | Pharmaceutical compositions containing dispersible fluoxetine | |
DE69905368D1 (en) | Oxydiertes thymosin beta 4 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EC2A | Search report published |
Date of ref document: 19941213 Kind code of ref document: B1 Effective date: 19941213 |